Corporate & Investor Presentation

SaaS portfolio is operating at scale and creating value Portfolio is financially attractive on its own and with leading positions in key segments. $ 27 2020 ResMed | Corporate & Investor Presentation - updated 05AUG20 Supports growth for existing businesses (HME) and chronic diseases, sleep apnea and COPD in particular. Breadth and scale creates our competitive advantage. ResMed

View entire presentation